FINQUEST
USPTO Trademark Record · Serial No. 75931689
Trademark details
It was initially claimed by Genome Therapeutics Corporation on 20000229.
That brand applies to the following goods and services:Chemicals, namely, therapeutic agents in the nature of genomic drugs, polypeptides, proteins and genes for use in the pharmaceutical industry, Therapeutic agents, namely, drugs, polypeptides, deoxyribonucleic acid (DNA), proteins and genes for use in the treatment of human diseases and disorders, Computer software, featuring a database used for genetic or protein analysis; computer hardware and computer peripherals, Biotechnology research and development services in the field of genomic research, namely drug development and repositioning; designing clinical trials; genomic sequencing and finishing, single nucleotide polymorphism (SNP) detection and haplotyping, providing genomic, polypeptide and protein information; generating genomes; pharmocogenomics, diagnostics and therapeutics pertaining to disease states and conditions.
Currently that trademark is represented by trademark attorney(s): Fred W. Hathaway.
You can learn more about that trademark on the USPTO website: View the USPTO record
Services available
Questions about this trademark?
If you have questions or issues related to the FINQUEST trademark — or to trademarks in general — our trademark attorneys can help. No appointment needed: call us or request a free estimate.
Register a Trademark Get a Free Estimate
